glioma

Prayers From Maria - Children's Glioma Cancer Foundation Hosts Sunflower Soiree

CLEVELAND, Feb. 3 /PRNewswire/ -- Prayers From Maria - Children's Glioma Cancer Foundation will be hosting its second annual Sunflower Soiree. WHAT: The Sunflower Soiree WHEN: 7 p.m. - 1 a.m., Saturday, February 21, 2009 WHERE: The Corner Alley, 402 Euclid Ave., Downtown Clev...

Avastin and Other Emerging Agents Will Drive the Glioma Drug Market to More Than $1.8 Billion in 2017

Generic Erosion Will Reduce Sales of Schering-Plough's Temodar/Temodal, the Current Market Leader, According to a New Report from Decision Resources WALTHAM, Mass., Dec. 8 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and hea...

Surveyed Oncologists Indicate that Avastin has Advantages over Temodar/Temodal in Increasing Overall Survival of High-Grade Glioma

A Drug That Improves Survival, When Added to Temodar/Temodal, Would Earn a 65 Percent Patient Share in the U.S. and a 30 Percent Patient Share in Europe in Newly Diagnosed Glioblastoma Multiforme, According to a New Report from Decision Resources WALTHAM, Mass., March 9 /PRNewswire/ -- Deci...

Surveyed Oncologists Expect to Prescribe Provenge to about Half of Their Prostate Cancer Patients if the Vaccine is Approved

...tudes Toward Emerging Cancer Vaccines for Prostate Cancer, Lung Cancer, and glioma finds that clinicians are willing to prescribe Provenge to patients in the...tudes Toward Emerging Cancer Vaccines for Prostate Cancer, Lung Cancer, and glioma is based on a U.S. survey of 70 oncologists, 71 urologists and 20 MCO phar...

Most common brain cancer may start in neural stem cells

...M scientists show that the expression of mutant p53 protein is a marker for glioma cells in all stages of the disease. "Now, if we believe that the SVZ is...dence supports the idea that mutant p53 can be a useful marker to trace the glioma cells at all stages. What's next: Before any treatments based on th...

Most common brain cancer may originate in neural stem cells

...M scientists show that the expression of mutant p53 protein is a marker for glioma cells in all stages of the disease. "Now, if we believe that the SVZ is...dence supports the idea that mutant p53 can be a useful marker to trace the glioma cells at all stages. What's next: Before any treatments based on th...

Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program

...ence #: 150240 Publication No.: 445 Abstract Title: Dosimetry of phase I interstitial 131I-chTNT-1/B MAb (Cotara) for the treatment of recurrent glioma Accepted to: ISRTRD Integrated Session (Oral) Session Info: Dosimetry/Radiobiology IV: Targeted, Diagnostic and Therapeutic Agents Tuesday, J...

Delivering Chemo Directly Into Brain Tumors Shows Promise

...t 3 percent of patients diagnosed with a malignant glioma survive five years or more, according to backgroun...y. Even when there's no tumor visible, microscopic glioma cells usually remain that eventually regrow, Fishe...d been shown to be effective in killing malignant glioma cells, but delivering enough of it through the blo...

USC researchers develop new drug to target tumor cells and blood vessels

...tiveness of the DMC compound by isolating endothelial cellsthe cells that line the interior surface of blood vesselsfrom human nonmalignant brain and glioma tissues and treating them with DMC. They found that the drug was cytotoxic to tumor-associated endothelial cells and suppressed cell proliferation...

Neurosurgeons from around the world gather at PLA 301 Hospital in China

...ve procedures in the first week of operation. In the six weeks since installation of the IMRISneuro suite, the team treated 43 patients suffering with glioma or epilepsy. While PLA 301 is widely-recognized for performing at the highest of global clinical standards, Dr. Xu Bainan, Chairman of Neurosurgery, s...

glioma in Medical Technology

Data from Investigator-Sponsored Trial of Oncophage Cancer Vaccine in Glioma Presented at American Association of Neurological Surgeons Annual Meeting

WASHINGTON--(BUSINESS WIRE)--Apr 16, 2007 - Antigenics Inc. (NASDAQ: AGEN) today announced an oral presentation of updated data from a Phase 1/2 investigator-sponsored trial of the company's investigational cancer vaccine Oncophage(R) (vitespen) in recurrent, high-grade glioma at the 75th annual me...

Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting

...er Board #J13; GU General Poster Session, May 31, 2:00 p.m.-6:00 p.m. glioma Fiveash J, et al. NABT-0702: A phase II study of AT-101 in recurrent gli... malignancies (with Rituxan(R)), small cell lung cancer (with Hycamtin(R)), glioma (with Temodar(R), +/- chemoradiotherapy [XRT]) and esophageal cancer (with ...

Cancer Research 'David' Hopes to Slay 'Cancer Goliath'

...liver, lung, spine, pancreas, prostate, ovary, and stomach. In addition, some effectiveness was seen in an instance of lymphoid leukemia, and one of a glioma of the ocular nerve. These tests preceded his more recent death due to an unfortunate accident. As a small Foundation hard hit by the untimely d...

Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer

... lung cancer (with Taxotere(R) [docetaxel]), B-cell malignancies (with Rituxan(R) [rituximab]), small cell lung cancer (with Hycamtin(R) [topotecan]), glioma (with Temodar(R) [temozolomide], +/- chemoradiotherapy [XRT]) and in esophageal cancer (with docetaxel, 5-fluorouracil and XRT). Recently, two double-...

YM BioSciences Announces Milestone Payment For Approval Of Nimotuzumab In The Philippines And Indonesia

...advanced in several randomized Phase II and III trials in Japan, Europe and elsewhere and is undergoing a YM-sponsored confirmatory trial in pediatric glioma in Canada and the US. NYSE Alternext US notice The Company received an audit opinion for the fiscal year ended June 30, 2008 which i...

Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months

...-formulated vaccine containing a peptide from Tyrosinase-Related Protein 2 (TRP-2), an antigen commonly expressed by several types of tumors including glioma and melanoma, resulted in approximately a 100-fold increase in antigen-specific CD8+ T-cell responses compared with unformulated vaccine. CD8+ T-cells...

Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials

... A recent article published in Neuro-Oncology (Lamborn et al, 2008) examined six-month progression free survival as a predictor of overall survival in glioma patients. The article included data from 597 adult patients with recurrent high-grade gliomas that enrolled in Phase II trial protocols collected by t...

Light Sciences Oncology Raises $40.1 Million in Series C Financing

...o the liver, the company has completed a Phase II clinical trial of Litx in glioma and plans to initiate a Phase III trial in glioma during the second half of 2008. LSO has widened the scope of potential ther...

Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate

... expects to initiate a Phase III clinical study in glioma in the second half of 2008. BPH is a common resu...has completed a Phase II clinical trial of Litx in glioma and plans to initiate a Phase III trial in glioma during the second half of 2008. LSO has widened th...

Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements

...ssion rate was accepted as the endpoint for conditional approval. The drug designed for the targeted treatment of recurrent or refractory high-grade glioma was administered as monotherapy and compared to standard chemotherapy in an international, randomized, active-controlled Phase IIb clinical trial. Eff...

glioma in Medical Definition

Pathology

...yosarcoma - Rhabdomyoma / rhabdomyosarcoma - Mesothelioma - Angioma / angiosarcoma - Osteoma / osteosarcoma - Chondroma / chondrosarcoma - glioma - Lymphoma / leukemia Treatment Surgery - Chemotherapy - Radiation therapy - Immunotherapy - Experimental cancer treatment ...

Ocular oncology

...yosarcoma - Rhabdomyoma / rhabdomyosarcoma - Mesothelioma - Angioma / angiosarcoma - Osteoma / osteosarcoma - Chondroma / chondrosarcoma - glioma - Lymphoma / leukemia Treatment Surgery - Chemotherapy - Radiation therapy - Immunotherapy - Experimental cancer treatment ...

glioma in Medical Dictionary

Optic glioma

Comprehensive information about optic gliomas , which affect one or both the optic nerves, or the optic chiasma. An optic pathway glioma is a tumor arising from a specific type of glial cell ... This hormone center can be affected by a glioma of the optic pathway system. .....

Gliomas

... A glioma is a type of cancer that starts in the brain or spine. It is called a glioma because it arises from glial cells. The most commo...esothelioma, breast cancer, and more. About glioma tumors, which usually occur in the lobes of the u...

Brain tumor

...s brain and spinal tumors and how they affect the mind, emotions, and personality. Find other information about brain cancer, otherwise known as glioma or ... Publications, treatment, and support resources. ... manual for patients featuring brain anatomy, tumors , related terminology, diagn...

glioma in Biological News

Mobile phone use not linked to increased risk of glioma brain tumours

Mobile phones are not associated with an increased risk of the most common type of brain tumour, finds the first UK study of the relationship between mobile phone use and risk of glioma. The results are published online by the BMJ today. The four year study by the Universities of Leeds, Nottingha...

Computer model predicts brain tumor growth and evolution

...was suffering from this type of tumor, a malignant glioma of the brain. Details of the research were high... game. The result: A three-dimensional matrix of a glioma that can be adjusted to see what its growth stage ...searchers validated their computational model with glioma specimens. Bearer studied about 40 different human...

Lithium may help radiation target cancer, spare healthy tissue

... NHEJ pathway. However, none of these effects were observed in malignant glioma (brain tumor) cells, presumably because cancer cells generally utilize a di... the safety and feasibility of lithium treatment in patients with low-grade glioma or brain metastases from small cell lung cancer. "Right now, the problem...

TGen researchers discover possible way to block the spread of deadly brain tumors

...as meant a fast maturation of NHERF-1 from a candidate gene associated with glioma invasion to positioning it as having a verified role in contributing to the...bacher said. In the study, depletion of NHERF-1 stopped the migration of glioma brain cancer cells, she said. "These results suggest that NHERF-1 plays a...

Engineers create intelligent molecules that seek-and-destroy diseased cells

...es where it is not doing what we would like it to do," Smolke said. She hopes to translate her technologies into intelligent cellular therapeutics for glioma patients in the next five years. "That's a very optimistic view," she said. "But so far things have been moving quickly." The broader implications f...

Veterinary college researcher studying brain tumors in people and animals

...l and are currently enrolling animals from around the region that have been positively diagnosed with a brain mass consistent with the appearance of a glioma on magnetic resonance imaging (MRI). The researchers will be studying tissue samples from affected animals in search of these proteins that are not...

Invasion of the brain tumors

...ite outgrowth and promote neuronal cell death, as an important regulator of glioma invasion. The researchers present the first evidence that this neurotrophin receptor can also be a potent mediator of glioma invasion, and they show that the expression of this receptor is sufficient ...

UCSF brain tumor vaccine trial shows promising results

...o seek out second opinions and investigate clinical trials. I can tell you I am so glad I did.? “Our goal is to change the management of recurrent glioma from a life threatening disease, in which survival rates are typically 25 to 26 weeks, into a chronic disease with extended survival and improved qual...

Newly identified biomarker detects and regulates spread of brain tumors

...reads or comes back after treatment. The study, ÒAttractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration," is published in the November issue of Clinical Cancer Research. The biomarker, a protein known as "soluble attractin," is normall...

Vaccine for brain tumors shows promising results

...patients with recurrent, high-grade glioma. glioma is a type of primary tumor that arises from the gl...e cells. The most common site of involvement of a glioma is the brain. Malignant glioma is currently a fatal disease. The trial resu...

glioma in Biological Technology

Oncolytics Biotech(R) Inc. Research Collaborators Present Glioma Reovirus Research at ASV Annual Meeting

CALGARY, July 15 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY ) announced today that a poster presentation by Dr. Jacqueline Parker et al. entitled "Anti-Tumor Activity of Reovirus is Synergistically Enhanced in Combination with Temozolomide and Low Dose Irradiation i...

Is Earlier Detection of Cancers Such as Glioma Possible?

BOSTON, May 21 /PRNewswire/ -- Oncolab, Inc.'s AMAS(R) Test ( http://www.oncolabinc.com ) is a commercially available blood test that may allow early detection of a wide range of human cancers. It detects a circulating, cancer-specific antibody, the Anti-malignin antibody, in human serum. An...

YM BIOSCIENCES', EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER

MISSISSAUGA, ON, Aug. 21 /PRNewswire-FirstCall/ - YM BioSciences Inc. (AMEX: YMI , TSX: YM, AIM: YMBA), an oncology company that identifies, develops and commercializes differentiated products for patients worldwide, today announced that Oncoscience AG (Wedel, Germany), its European partner f...

YM BIOSCIENCES' SUBSIDIARY RESOLVES PROPOSED ARBITRATION WITH ONCOSCIENCE AG

...ion to the clinical program being undertaken globally for this promising drug. Recruitment of our Phase III trial in newly diagnosed pediatric pontine glioma has been concluded and we anticipate that recruitment in our randomised Phase III trial in adult glioblastoma grade IV will be completed in 2009. We a...

YM BIOSCIENCES REPORTS THIRD QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS

...s into a randomized Phase III study evaluating nimotuzumab in adult glioma patients and into a randomized Phase IIb/IIIa trial in patients wit...ued to enroll children with progressive, diffuse, intrinsic pontine glioma (DIPG) into a Phase II trial at multiple sites in the US, Canada an...

Telik Reports Preclinical Results at AACR Annual Meeting

...oth orally and parenterally against a wide variety of human tumor types, including breast, pancreatic, prostate, and colorectal carcinomas, as well as glioma and promyelocytic leukemia. Telik, Inc. of Palo Alto, CA, is a clinical stage drug development company focused on discovering and...

YM BIOSCIENCES REPORTS SECOND QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS

... in a randomized Phase III study evaluating nimotuzumab in adult glioma patients and a randomized Phase IIb/IIIa trial in patients with adv...ued to enroll children with progressive, diffuse, intrinsic pontine glioma (DIPG) into a Phase II trial at multiple sites in the US, Canada an...

Diffusion Pharmaceuticals Announces Completion of a $2.9 Million Private Placement and Company Presentations at Upcoming Industry Conferences in Geneva, Switzerland and Naples, Florida

...ents suffering from intermittent claudication. In early 2009, the company will initiate a Phase I proof-of-mechanism trial in patients with high-grade glioma at Johns Hopkins University . These studies are designated NCT00725881 and NCT00826930 , respectively, on the clinicaltrials.gov Website. Diffusio...

YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG CANCER

...al randomized Phase II and III trials in Japan, South East Asia, Europe and elsewhere and is undergoing a YM-sponsored confirmatory trial in pediatric glioma in Canada and the US. The National Cancer Centre of Singapore (NCCS) recently announced that it has selected nimotuzumab for evaluation in the adjuvan...

YM BIOSCIENCES PROVIDES EU REGULATORY UPDATE

... this molecule to be best-in-class in an established area of cancer therapy. It is currently undergoing a YM sponsored confirmatory trial in pediatric glioma in Canada and the US while being advanced in several Phase II and III trials by YM's licensees and other companies advancing the drug internationally....